新冠病毒檢測套組市場規模、佔有率及成長分析（依產品類型、檢體/樣本類型、最終用戶、檢測方法及地區分類）－2026-2033年產業預測

預計到 2024 年，全球 COVID-19檢測套組市場規模將達到 861.9 億美元，到 2025 年將成長至 927.4 億美元，到 2033 年將成長至 1666.3 億美元，預測期（2026-2033 年）的複合年成長率為 7.6%。

儘管大規模檢測力度下降，但持續的公共衛生監測和感染族群對檢測的持續需求仍然是全球新冠病毒檢測套組市場的主要驅動力。在都市區，數位醫療解決方案和電子商務的普及使得居家檢測更加便捷，從而推動了自測檢測套組的廣泛應用。鼻拭子和唾液檢測因其便利性而備受青睞。能夠同時檢測多種呼吸道病毒的多重診斷技術投資正在蓬勃發展，吸引了尋求經濟高效解決方案的衛生部門的關注。此外，人工智慧驅動的技術能夠加快偵測速度，提高使用者對偵測結果的信心，無論是在家中或在檢查室進行檢測。儘管市場成長前景可期，但市場飽和和成本壓力等挑戰依然存在，這使得檢測套組產業的發展道路充滿挑戰，但也充滿希望。

全球新冠病毒檢測套組市場促進因素

全球新冠病毒檢測套組市場的主要促進因素是對感染疾病早期檢測和快速反應的日益重視。隨著世界各國公共衛生機構和政府將控制和預防新冠病毒傳播的策略置於優先地位，對可靠檢測解決方案的需求不斷成長。人們對無症狀感染的認知不斷提高，以及對準確快速診斷的需求，推動了包括PCR檢測和抗原檢測在內的各種檢測方法的應用。此外，不斷提高檢測準確性和速度的技術進步也在持續推動創新和市場成長，以滿足醫療機構和公眾的需求。

全球新冠病毒檢測套組市場面臨的限制因素

全球新冠病毒檢測套組市場的主要限制因素之一是現有檢測方案的飽和，加劇了製造商之間的競爭。居家檢測和就地檢驗方案的快速普及導致市場碎片化，可能引發價格戰並降低企業的利潤率。此外，不斷變化的監管環境和各地區的核准流程差異也使得新產品難以持續進入市場。而且，隨著疫苗接種率的提高，大眾對檢測的疲勞感和需求的下降可能會進一步限制該領域製造商的成長機會，因此產品創新和多元化至關重要。

全球新冠病毒檢測套組市場趨勢

全球新冠病毒檢測套組市場正經歷著向自我檢測和居家診斷的重大轉變，這主要受分散式醫療解決方案需求的驅動。尤其是在疫情反覆爆發的情況下，基於唾液的抗原檢測套組因其易用性而日益受到消費者的青睞，它們提供了一種無需臨床環境即可進行的經濟便捷的檢測方法。監管核准的加強也推動了這一趨勢，促進了居家檢測解決方案的廣泛應用。這一趨勢不僅增強了消費者在健康管理方面的自主權，也反映了醫療服務模式的更廣泛變革，並正在塑造診斷檢測的未來。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境
• 客戶和購買標準分析
• 原料分析

全球新冠病毒檢測套組市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• RT-PCR檢測試劑盒
• 免疫檢測測定試紙/試劑盒
• 基於CRISPR的分子診斷試劑盒
• 其他分子檢測試劑盒

全球新冠病毒檢測套組市場規模（依檢體/樣本類型分類）及複合年成長率（2026-2033 年）

• 鼻咽拭子
• 口咽拭子
• 鼻拭子
• 唾液樣本
• 血液/指尖血液採樣

全球新冠病毒檢測套組市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院和診所
• 診斷檢查室
• 居家照護/自我檢測
• 公共衛生機構
• 其他

全球新冠病毒檢測套組市場規模（依檢測方法分類）及複合年成長率（2026-2033 年）

• 集中式檢查室檢測（非即時檢測）
• 照護現場偵測 (POC)
• 店面銷售（OTC）自測檢測套組

全球新冠病毒檢測套組市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

主要企業簡介

• Abbott Laboratories
• Thermo Fisher Scientific
• Roche Diagnostics
• BGI Group
• Qiagen
• Quidel Corporation
• Mylab Discovery Solutions
• SD Biosensor
• BioMerieux SA
• Danaher Corporation
• Hologic Inc.
• Seegene Inc.
• PerkinElmer Inc.
• Randox Laboratories
• CEPI（Collaborative entities）
• Guangzhou Wondfo Biotech
• Shenzhen Bioeasy Biotechnology
• Cepheid Inc.
• 1drop Inc.
• ADT Biotech

結論與建議

Global COVID Testing Kit Market size was valued at USD 86.19 Billion in 2024 and is poised to grow from USD 92.74 Billion in 2025 to USD 166.63 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The global market for COVID testing kits is currently shaped by ongoing public health monitoring and the sustained demand for testing among affected populations, despite a decline in mass screening initiatives. Urban centers have embraced self-test kits, aided by digital health solutions and e-commerce, making home diagnostics more convenient. Nasal swab and saliva tests are preferred for their ease of use. Investment in multiplex diagnostics has surged, allowing for the detection of multiple respiratory viruses, thereby appealing to health agencies seeking cost-effective solutions. Additionally, AI-driven technologies have streamlined results, enhancing user confidence in both home and laboratory testing. Although market growth is expected, challenges persist from oversaturation and cost pressures, indicating a turbulent yet promising trajectory ahead for the testing kit sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global COVID Testing Kit market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global COVID Testing Kit Market Segments Analysis

Global COVID Testing Kit Market is segmented by Product Type, Specimen / Sample Type, End-User, Mode of Testing and region. Based on Product Type, the market is segmented into RT-PCR Assay Kits, Immunoassay Test Strips / Cassettes, CRISPR-Based Molecular Kits and Other Molecular Kits. Based on Specimen / Sample Type, the market is segmented into Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Saliva Sample and Blood / Finger-Prick. Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Laboratories, Home Care / Self-Testing, Public Health Agencies and Others. Based on Mode of Testing, the market is segmented into Centralized Lab Testing (Non-POC), Point-of-Care (POC) Testing and Over-The-Counter (OTC) Self-Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global COVID Testing Kit Market

A key market driver for the global COVID testing kit market is the rising emphasis on early detection and rapid response to infectious diseases. As public health authorities and governments worldwide prioritize strategies to control and prevent the spread of COVID-19, there is increased demand for reliable testing solutions. The growing awareness of asymptomatic cases and the need for accurate, timely diagnosis are propelling the adoption of various testing methods, including PCR and antigen tests. Furthermore, advancements in technology that enhance the accuracy and speed of testing processes continue to spur innovation and market growth, catering to both healthcare providers and the general public.

Restraints in the Global COVID Testing Kit Market

One key market restraint for the global COVID testing kit market is the saturation of available testing solutions, leading to increased competition among manufacturers. The rapid proliferation of at-home and point-of-care testing options has resulted in a fragmented market, causing price wars that can diminish profit margins for companies. Additionally, the evolving regulatory landscape and varying approval processes across regions can challenge consistent market entry for new products. Furthermore, public fatigue regarding testing and a decline in demand as vaccination rates rise may further restrict growth opportunities for manufacturers in this sector, making it crucial to innovate and diversify offerings.

Market Trends of the Global COVID Testing Kit Market

The global COVID testing kit market is experiencing a significant shift towards self-testing and home diagnostics, spurred by the demand for decentralized healthcare solutions. The advent of user-friendly, saliva-based antigen kits has gained traction among consumers, as they offer an affordable and convenient option for testing with reduced reliance on clinical settings, particularly amid recurring infection waves. Enhanced regulatory approvals have further supported this trend, leading to increased adoption of at-home testing solutions. This movement not only promotes consumer empowerment in health management but also reflects a broader transformation in healthcare delivery, shaping the future landscape of diagnostic testing.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Raw Material Analysis

Global COVID Testing Kit Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• RT-PCR Assay Kits
• Immunoassay Test Strips / Cassettes
• CRISPR-Based Molecular Kits
• Other Molecular Kits

Global COVID Testing Kit Market Size by Specimen / Sample Type & CAGR (2026-2033)

• Market Overview
• Nasopharyngeal Swab
• Oropharyngeal Swab
• Nasal Swab
• Saliva Sample
• Blood / Finger-Prick

Global COVID Testing Kit Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals & Clinics
• Diagnostic Laboratories
• Home Care / Self-Testing
• Public Health Agencies
• Others

Global COVID Testing Kit Market Size by Mode of Testing & CAGR (2026-2033)

• Market Overview
• Centralized Lab Testing (Non-POC)
• Point-of-Care (POC) Testing
• Over-The-Counter (OTC) Self-Testing

Global COVID Testing Kit Market Size & CAGR (2026-2033)

• North America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • US
  • Canada
• Europe (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Specimen / Sample Type, End-User, Mode of Testing)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qiagen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylab Discovery Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Seegene Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CEPI (Collaborative entities)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Guangzhou Wondfo Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Bioeasy Biotechnology
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 1drop Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ADT Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations